Strategies for Developing a Potency Assay for a Clonal Neoantigen-Reactive Cell Therapy Product

Time: 12:30 pm
day: Day One


• Showcasing options for measuring potency effectively
• Discussing data generation in Phase I trials
• Transition from early stage to late-stage development for potency assays
• Supporting characterization and development by designing phase appropriate potency assay